{
  "url": "https://openlegislation.uk/eu-directive-2011-46/annex",
  "json_url": "https://openlegislation.uk/eu-directive-2011-46/annex.json",
  "legislation": "eudr/2011/46",
  "legislation_title": "Commission Implementing Directive 2011/46/EU of 14 April 2011 amending Council Directive 91/414/EEC to include hexythiazox as active substance and amending Commission Decision 2008/934/EC (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2011-46",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:\nFurther details on identity and specification of active substance are provided in the review report.\n(4S,5S)-5-(4-chlorophenyl)-4-methyl-1,3-thiazolidin-2-one and (4R,5R)-5-(4-chlorophenyl)-4-methyl-1,3-thiazolidin-2-one.\nNo\nCommon name, identification numbers\nIUPAC name\nPurity\nEntry into force\nExpiration of inclusion\nSpecific provisions\n‘343\nHexythiazox\nCAS No 78587-05-0\nCIPAC No 439\n(4RS,5RS)-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-1,3-thiazolidine-3-carboxamide\n≥ 976 g/kg\n(1:1 mixture of (4R, 5R) and (4S, 5S))\n1 June 2011\n31 May 2021\nPART A\nOnly uses as acaricide may be authorised.\nPART B\nFor the implementation of the uniform principles of Annex VI, the conclusions of the review report on hexythiazox, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 11 March 2011 shall be taken into account.\nIn this overall assessment Member States shall pay particular attention to:\nthe protection of aquatic organisms. Conditions of use shall include risk mitigation measures, where appropriate,\nthe operators and workers safety. Conditions of use shall include protective measures, where appropriate.\nThe Member States concerned shall request the submission of confirmatory information as regards:\n(a) the toxicological relevance of the metabolite PT-1-3;\n(b) the potential occurrence of the metabolite PT-1-3 in processed commodities;\n(c) the potential adverse effects of hexythiazox on bee brood;\n(d) the possible impact of the preferential degradation and/or conversion of the mixture of isomers on the worker risk assessment, the consumer risk assessment and the environment.\nThe Member States concerned shall ensure that the applicant submits to the Commission the information set out in points (a), (b) and (c) by 31 May 2013 and the information set out in point (d) 2 years after the adoption of specific guidance.’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Further details on identity and specification of active substance are provided in the review report."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "(4S,5S)-5-(4-chlorophenyl)-4-methyl-1,3-thiazolidin-2-one and (4R,5R)-5-(4-chlorophenyl)-4-methyl-1,3-thiazolidin-2-one."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2011/46/annex",
    "retrieved_at": "2026-11-01T15:22:01.154609+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}